Skip to content

Whole exome sequencing in patients with Idiopathic Ventricular Fibrillation and familial Atrial Fibrillation

Whole exome sequencing in patients with Idiopathic Ventricular Fibrillation and familial Atrial Fibrillation - The W-IVF/W-AF study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42277
Enrollment
70
Registered
2015-06-08
Start date
2015-09-17
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation of unknown origin life-threatening ventricular rythm disorder of unknown origin

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with iVF: All documented patients with: • A sudden cardiac arrest with initial rhythm of VF. • Who were diagnosed with iVF after careful phenotyping and exclusion of all structural or primary electrical cardiac disease. • In whom regular genetic testing has not detected a known gene mutation associated with the occurrence of VF. ;Patients with (familial) lone AF • Patients with at least 1 episode of documented AF • No present structural or systemic cause for AF, excluded by past medical history, anamnesis, physical examination, laboratory results, electrocardiogram, X-thorax and echocardiography •

Exclusion criteria

Exclusion criteria: • Patients not capable of giving inform consent •

Design outcomes

Primary

MeasureTime frame
The detection of the underlying genetic cause of patients with IVF and fAF by: 1. The evaluation of the genetic burden of pathogenic mutations in a diagnostic panel of 212 cardiomyopathy genes. 2. The detection of novel genes/genetic factors responsible for IVF and fAF.

Secondary

MeasureTime frame
1. The correlation of the presence of gene defects and response to catheter ablation in AF patients. 2. The understanding of the pathophysiological mechanism and disease pathways of iVF and familial lone AF with functional studies using the extensive UMCU network with collaboration of the departments of biostatistics, medical physiology, experimental cardiology and the Hubrecht institute.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)